午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

7-chloro-4-[(4-methoxyphenyl)methyl]-2-methyl-5-oxo-2H,4H,5H-pyrazolo[4,3-b]pyridine-6-carbaldehyde

CAS No.
2338863-44-6
Chemical Name:
7-chloro-4-[(4-methoxyphenyl)methyl]-2-methyl-5-oxo-2H,4H,5H-pyrazolo[4,3-b]pyridine-6-carbaldehyde
Synonyms
7-chloro-4-[(4-methoxyphenyl)methyl]-2-methyl-5-oxo-2H,4H,5H-pyrazolo[4,3-b]pyridine-6-carbaldehyde;2H-Pyrazolo[4,3-b]pyridine-6-carboxaldehyde, 7-chloro-4,5-dihydro-4-[(4-methoxyphenyl)methyl]-2-methyl-5-oxo-
CBNumber:
CB414299092
Molecular Formula:
C16H14ClN3O3
Molecular Weight:
331.75
MDL Number:
MOL File:
2338863-44-6.mol

7-chloro-4-[(4-methoxyphenyl)methyl]-2-methyl-5-oxo-2H,4H,5H-pyrazolo[4,3-b]pyridine-6-carbaldehyde Properties

Boiling point 507.7±50.0 °C(predicted)
Density 1.38±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)
pka -1.77±0.20(predicted)

7-chloro-4-[(4-methoxyphenyl)methyl]-2-methyl-5-oxo-2H,4H,5H-pyrazolo[4,3-b]pyridine-6-carbaldehyde Preparation Products And Raw materials

Raw materials

Preparation Products

7-chloro-4-[(4-methoxyphenyl)methyl]-2-methyl-5-oxo-2H,4H,5H-pyrazolo[4,3-b]pyridine-6-carbaldehyde Suppliers

Global( 2)Suppliers
Supplier Tel Email Country ProdList Advantage
Pharmalego 13472578225 18321033991 marketing@pharmalego.com China 2964 58
Taizhou Zhongzhi Biotechnology Co., Ltd 13012344321 3995296515@qq.com China 7996 58
7-chloro-4-[(4-methoxyphenyl)methyl]-2-methyl-5-oxo-2H,4H,5H-pyrazolo[4,3-b]pyridine-6-carbaldehyde 2H-Pyrazolo[4,3-b]pyridine-6-carboxaldehyde, 7-chloro-4,5-dihydro-4-[(4-methoxyphenyl)methyl]-2-methyl-5-oxo- 2338863-44-6
This site uses cookies
This website uses cookies and similar technologies to store and retrieve information about your use of this website. This information helps us to provide, analyse and improve our services, which may include personalised content or advertising. We may share this information with Google and other third parties. This cookies are necessary for our website to work properly . By clicking "Continue" or continuing to browse our site you are agreeing to our and our partners use of cookies.
Accept